Showing results (1141-1150 of 1,186) with videos related to

Sort By:
Pageof 119
Archives of Environmental Health|June 23, 2006
Gliomas and farm pesticide exposure in men: the upper midwest health studyAvima M Ruder, Martha A Waters, Mary Ann Butler, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|April 18, 2026
Cannabis and Tobacco Co-Use is Associated with Impaired Neurocognitive Performance in Individuals at Clinical High Risk for PsychosisDaniel Bello, Jillian G Connolly, Jean Addington, et al.
Current Biology : CB|December 5, 2006
Molecular evidence for species-level distinctions in clouded leopardsValerie A Buckley-Beason, Warren E Johnson, Willliam G Nash, et al.
The Journal of Rheumatology|September 3, 2019
Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of VasculitisAlicia Rodriguez-Pla, Roscoe L Warner, David Cuthbertson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2018
Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated VasculitisAlvise Berti, Roscoe Warner, Kent Johnson, et al.
Cancer Research|November 18, 2008
Identification of alternative splicing markers for breast cancerJulian P Venables, Roscoe Klinck, Anne Bramard, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2010
CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphomaNadia N Laack, Brian Patrick O'Neill, Karla V Ballman, et al.
British Journal of Sports Medicine|June 2, 2020
The Stanford Hall consensus statement for post-COVID-19 rehabilitationRobert M Barker-Davies, Oliver O'Sullivan, Kahawalage Pumi Prathima Senaratne, et al.
Journal of Neuro-Oncology|January 12, 2010
Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBMKurt A Jaeckle, Karla V Ballman, Caterina Giannini, et al.
Nature Communications|September 12, 2014
Human Tra2 proteins jointly control a CHEK1 splicing switch among alternative and constitutive target exonsAndrew Best, Katherine James, Caroline Dalgliesh, et al.
Pageof 119